It has been demonstrated that since MELD began to be used, the annual number of deaths of patients on waiting lists has greatly diminished. In addition, even though very ill patients have received transplants, there is no proof that post LT survival has decreased 16.
Se ha demostrado que con el uso del MELD se ha disminuido en forma significativa el número de muertes anuales de pacientes que fallecían en lista de espera, y a pesar de que se trasplantan pacientes muy enfermos, no se ha demostrado una disminución en la sobrevida post TH 16.